Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New Haven, CT
SEC filing record 1 source field available
Fiscal year end
31 December
BioXcel Therapeutics, Inc. has filed 662 SEC EDGAR filings since 13 Nov 2017

SEC filing history

Showing 126-150 of 662 matching filings.

Per page
25
Current page
6
4

OWNERSHIP DOCUMENT

Filing date
04 Mar 2025
Reporting date
28 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-275261

424B5

Filing date
04 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90437

SCHEDULE 13G filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
04 Feb 2025
Reporting date
31 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-284224

EFFECT filing

Filing date
17 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
16 Jan 2025
Reporting date
15 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
16 Jan 2025
Reporting date
15 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-284224

UPLOAD filing

Filing date
15 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
10 Jan 2025
Reporting date
07 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
10 Jan 2025
Reporting date
07 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
10 Jan 2025
Reporting date
07 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-284224

S-3

Filing date
10 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Jan 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38410

DEF 14A

Filing date
30 Dec 2024
Reporting date
28 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90437

SCHEDULE 13G filing

Filing date
18 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-90437

SCHEDULE 13G filing

Filing date
18 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-38410

PRE 14A

Filing date
18 Dec 2024
Reporting date
28 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
17 Dec 2024
Reporting date
14 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .